APASL 1000 1030 n.theise
-
Upload
neil-theise -
Category
Documents
-
view
430 -
download
2
description
Transcript of APASL 1000 1030 n.theise
![Page 1: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/1.jpg)
Stem Cells andHepatocarcinogenesis
Neil Theise, MDDepts. of Pathology and Medicine
Beth Israel Medical Center – Albert Einstein College of MedicineNew York City
www.neiltheise.com
![Page 2: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/2.jpg)
Differentiation-Inducing Activity of Hydroxycamptothecin on Cancer Stem-Like Cells Derived from Hepatocellular Carcinoma. Zhang Y, Song WJ, Zhang FQ, Liu WH, Dou KF. Dig Dis Sci. 2011 Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma. Shibuya M, Kondo F, Sano K, Takada T, Asano T. J Hepatobiliary Pancreat Sci. 2011 MicroRNAs involved in neoplastic transformation of liver cancer stem cells. Li R, Qian N, Tao K, You N, Wang X, Dou K. J Exp Clin Cancer Res. 2010 Dec 23;29:169. Complete response in 5 out of 38 patients with advanced hepatocellular carcinoma treated with stem cell differentiation stage factors: case reports from a single centre. Livraghi T, Ceriani R, Palmisano A, Pedicini V, Pich MG, Tommasini MA, Torzilli G. Curr Pharm Biotechnol. 2011 Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulation. Lee TK, Castilho A, Cheung VC, Tang KH, Ma S, Ng IO. Hepatology. 2011 Jan;53(1):160-70. The cyclin E regulator cullin 3 prevents mouse hepatic progenitor cells from becoming tumor-initiating cells. Kossatz U, Breuhahn K, Wolf B, Hardtke-Wolenski M, Wilkens L, Steinemann D, Singer S, Brass F, Kubicka S, Schlegelberger B, Schirmacher P, Manns MP, Singer JD, Malek NP. J Clin Invest. 2010 Nov 1;120(11):3820-33 Invasion and EMT-associated genes are up-regulated in B viral hepatocellular carcinoma with high expression of CD133-human and cell culture study. Na DC, Lee JE, Yoo JE, Oh BK, Choi GH, Park YN. Exp Mol Pathol. 2011 Feb;90(1):66-73 Characterization of the epithelial cell adhesion molecule (EpCAM)+ cell population in hepatocellular carcinoma cell lines. Kimura O, Takahashi T, Ishii N, Inoue Y, Ueno Y, Kogure T, Fukushima K, Shiina M, Yamagiwa Y, Kondo Y, Inoue J, Kakazu E, Iwasaki T, Kawagishi N, Shimosegawa T, Sugamura K. Cancer Sci. 2010 Oct;101(10):2145-5 Cytoplasmic expression of CD133 is an important risk factor for overall survival in hepatocellular carcinoma. Sasaki A, Kamiyama T, Yokoo H, Nakanishi K, Kubota K, Haga H, Matsushita M, Ozaki M, Matsuno Y, Todo S. Oncol Rep. 2010 Aug;24(2):537-46. Collecting evidence for a stem cell hypothesis in HCC. Teufel A, Galle PR. Gut. 2010 Jul;59(7):870-1Expression of Oct4 in HCC and modulation to wnt/βcatenin and TGF-β signal pathways. Yuan F, Zhou W, Zou C, Zhang Z, Hu H, Dai Z, Zhang Y. Mol Cell Biochem. 2010 Oct;343(1-2):155-62Characterization of the epithelial cell adhesion molecule (EpCAM)+ cell population in hepatocellular carcinoma cell lines. Kimura O, Takahashi T, Ishii N, Inoue Y, Ueno Y, Kogure T, Fukushima K, Shiina M, Yamagiwa Y, Kondo Y, Inoue J, Kakazu E, Iwasaki T, Kawagishi N, Shimosegawa T, Sugamura K Cancer Sci. 2010 Oct;101(10):2145-55Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation. Yamashita T, Honda M, Nio K, Nakamoto Y, Yamashita T, Takamura H, Tani T, Zen Y, Kaneko S. Cancer Res. 2010 Jun 1;70(11):4687-97EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma. Terris B, Cavard C, Perret C. J Hepatol. 2010 Feb;52(2):280-1. What is the relationship among microRNA-181, epithelial cell-adhesion molecule (EpCAM) and beta-catenin in hepatic cancer stem cells. Li JP, Zheng JY, Du JJ, Zhang R, Yang AG. Hepatology. 2009 Dec;50(6):2047-Hepatic progenitor cells in liver cancers from Asian children. Ward SC, Thung SN, Lim KH, Tran TT, Hong TK, Hoang PL, Jang JJ, Park YN, Abe K. Liver Int. 2010 Jan;30(1):102-11EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Yamashita T, Ji J, Budhu A, Forgues M, Yang W, Wang HY, Jia H, Ye Q, Qin LX, Wauthier E, Reid LM, Minato H, Honda M, Kaneko S, Tang ZY, Wang XW. Gastroenterology. 2009 Mar;136(3):1012-24Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma. Lingala S, Cui YY, Chen X, Ruebner BH, Qian XF, Zern MA, Wu J. Exp Mol Pathol. 2010 Aug;89(1):27-35.
![Page 3: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/3.jpg)
Neil Theise, MDDepts. of Pathology and Medicine
Beth Israel Medical Center – Albert Einstein College of MedicineNew York City
www.neiltheise.com
Cancer and Stem Cells
and Stem Cell-derived Cancer and Cancer-derived Stem Cells
and… and… and… and…
![Page 4: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/4.jpg)
This talk has been posted on:
www.slideshare.net
Search: “Neil Theise”
![Page 5: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/5.jpg)
1. Are there hepatobiliary stem cells?
2. Is there evidence that hepatobiliary cancers arise fromstem cells?
3. How can hepatobiliary carcinomas arise from stem cells?
4. Do all hepatobiliary tumors, then, start from stem cells?
5. Do all hepatobiliary tumors have stem cells?
![Page 6: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/6.jpg)
1. Are there hepatobiliary stem cells?
Yes, in the: canals of Heringbile ductsbone marrow
Perhaps also:peribiliary “null cell” monocytesperibiliary hepatocytes
![Page 7: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/7.jpg)
stem cell
![Page 8: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/8.jpg)
stem cell
“assymetric division”
![Page 9: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/9.jpg)
stem cell
![Page 10: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/10.jpg)
stem cell
![Page 11: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/11.jpg)
stem cell
transit amplifying cells
![Page 12: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/12.jpg)
stem cell
transit amplifying cells
ductular reactions (humans)oval cells (rodents)
![Page 13: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/13.jpg)
stem cell
transit amplifying cells
drug resistanthypoxia resistant
radio-resistant
![Page 14: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/14.jpg)
stem cell
transit amplifying cells
drug resistanthypoxia resistant
radio-resistanti.e. resistant to
mutations
![Page 15: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/15.jpg)
stem cell
transit amplifying cells
drug resistanthypoxia resistant
radio-resistanttelomerase
![Page 16: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/16.jpg)
stem cell
transit amplifying cells
Keratin 19CD117 (c-kit)CD90 (thy-1)
EpCAMCD 133 (prominin-1)
ABC-G2
![Page 17: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/17.jpg)
Keratin 19CD117 (c-kit)CD90 (thy-1)
EpCAMCD 133 (prominin-1)
ABC-G2
stem cell
transit amplifying cells
“Side Population”
![Page 18: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/18.jpg)
1. Are there hepatobiliary stem cells?
2. Is there evidence that hepatobiliary cancers arise fromstem cells?
![Page 19: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/19.jpg)
Combined hepatocellular/cholangiocarcinomas
Is there evidence that hepatobiliary cancers arise from stem cells?
![Page 20: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/20.jpg)
Combined hepatocellular/cholangiocarcinomas
Combined HCC/ChC arising in a dysplastic nodule
Harada K, Terada T, Nakanuma Y, Furukawa Y, Kurumaya H.
A case of small combined hepatocellular and cholangiocellular carcinoma arising in a nodule of atypical adenomatous hyperplasia of the liver.
Am. J. Gastroenterol. 1993; 88; 1968–1969.
Is there evidence that hepatobiliary cancers arise from stem cells?
![Page 21: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/21.jpg)
Combined hepatocellular/cholangiocarcinomas
Combined HCC/ChC arising in a dysplastic nodule
“Stem cell tumors” of the liver
Is there evidence that hepatobiliary cancers arise from stem cells?
![Page 22: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/22.jpg)
1. Combined HCC-ChC2. Combined HCC-ChC with stem cell features
A. typical subtypeB. intermediate cell subtype C. cholangiocellular subtype
Chapter 10-4, N. D. Theise, O. Nakashima, Y. N. Park, Y. Nakanuma
![Page 23: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/23.jpg)
1. Are there hepatobiliary stem cells?
2. Is there evidence that hepatobiliary cancers arise fromstem cells?
3. How can hepatobiliary carcinomas arise from stem cells?
![Page 24: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/24.jpg)
Stem Cell Niche
![Page 25: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/25.jpg)
Stem Cell
Stromal Cell
![Page 26: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/26.jpg)
Immortal Strand Hypothesis
Stem cell retention of original DNA template
after replication and division
![Page 27: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/27.jpg)
Immortal Strand Hypothesis
Stem cell retention of original DNA template
after replication and division
SO: STEM CELLS SHOULDREMAIN FREE OF MUTATIONS
![Page 28: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/28.jpg)
Disordered stem cell retention of original DNA template
in chronic disease
e.g. inflammatory bowel diseaseprimary sclerosing cholangitismammary fibrocystic disease
chronic viral hepatitisH. pylori gastritis
![Page 29: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/29.jpg)
Disordered stem cell retention of original DNA template
in chronic disease
![Page 30: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/30.jpg)
Disordered stem cell retention of original DNA template
in chronic disease
![Page 31: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/31.jpg)
Disordered stem cell retention of original DNA template
in chronic disease
![Page 32: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/32.jpg)
Disordered stem cell retention of original DNA template
in chronic disease
MUTATION!!
![Page 33: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/33.jpg)
1. Are there hepatobiliary stem cells?
2. Is there evidence that hepatobiliary cancers arise fromstem cells?
3. How can hepatobiliary carcinomas arise from stem cells?
4. Do all hepatobiliary tumors, then, start from stem cells?
![Page 34: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/34.jpg)
Carcinogenesis
![Page 35: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/35.jpg)
1. Are there hepatobiliary stem cells?
2. Is there evidence that hepatobiliary cancers arise fromstem cells?
3. How can hepatobiliary carcinomas arise from stem cells?
4. Do all hepatobiliary tumors, then, start from stem cells? No. Mutations can probably happen in all cell types:
Stem cellsProgenitor cells (ductular reactions!)Fully differentiated cells
![Page 36: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/36.jpg)
1. Are there hepatobiliary stem cells?
2. Is there evidence that hepatobiliary cancers arise fromstem cells?
3. How can hepatobiliary carcinomas arise from stem cells?
4. Do all hepatobiliary tumors, then, start from stem cells?
5. Do all hepatobiliary tumors have stem cells?
![Page 37: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/37.jpg)
CancerStem CellEpCAMCD133
ABC-G2CD90
tumor
![Page 38: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/38.jpg)
CancerStem CellEpCAMCD133
ABC-G2CD90
tumor
Often tumor initiating…
![Page 39: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/39.jpg)
1. Are there hepatobiliary stem cells?
2. Is there evidence that hepatobiliary cancers arise fromstem cells?
3. How can hepatobiliary carcinomas arise from stem cells?
4. Do all hepatobiliary tumors, then, start from stem cells?
5. Do all hepatobiliary tumors have stem cells?
![Page 40: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/40.jpg)
1. Are there hepatobiliary stem cells?
2. Is there evidence that hepatobiliary cancers arise fromstem cells?
3. How can hepatobiliary carcinomas arise from stem cells?
4. Do all hepatobiliary tumors, then, start from stem cells?
5. Do all hepatobiliary tumors have stem cells?
Many do, though not necessarily all…
![Page 41: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/41.jpg)
1. Are there hepatobiliary stem cells?
2. Is there evidence that hepatobiliary cancers arise fromstem cells?
3. How can hepatobiliary carcinomas arise from stem cells?
4. Do all hepatobiliary tumors, then, start from stem cells?
5. Do all hepatobiliary tumors have stem cells?
So what…?
![Page 42: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/42.jpg)
cancerstem cell
drug resistanthypoxia resistant
radio-resistant
tumor
![Page 43: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/43.jpg)
tumor
Anti-tumor therapy
cancerstem cell
drug resistanthypoxia resistant
radio-resistant
![Page 44: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/44.jpg)
tumor
Anti-tumor therapy
cancerstem cell
drug resistanthypoxia resistant
radio-resistant
![Page 45: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/45.jpg)
tumor
Anti-tumor therapy
cancerstem cell
drug resistanthypoxia resistant
radio-resistant
![Page 46: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/46.jpg)
tumor
Anti-tumor therapy
cancerstem cell
drug resistanthypoxia resistant
radio-resistant
![Page 47: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/47.jpg)
Anti-tumor therapy
cancerstem cell
drug resistanthypoxia resistant
radio-resistant
![Page 48: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/48.jpg)
cancerstem cell
drug resistanthypoxia resistant
radio-resistant
![Page 49: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/49.jpg)
cancerstem cell
![Page 50: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/50.jpg)
cancerstem cell
![Page 51: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/51.jpg)
cancerstem cell
![Page 52: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/52.jpg)
cancerstem cell
![Page 53: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/53.jpg)
cancerstem cell
So: successful treatments will depend on new therapies that can successively eradicate tumor stem cells.
![Page 54: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/54.jpg)
In summary: Cancers can arise from stem cells
![Page 55: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/55.jpg)
In summary: Cancers can arise from stem cells
orCancers can arise from differentiated cells
![Page 56: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/56.jpg)
In summary: Cancers can arise from stem cells
orCancers can arise from differentiated cells
“Cancer stem cells” may refer to the stem cells from which cancers start,BUT generally refer to:
![Page 57: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/57.jpg)
In summary: Cancers can arise from stem cells
orCancers can arise from differentiated cells
“Cancer stem cells” can refer to the stem cells from which some cancers start,BUT generally refer to the: cells within a tumor that have stem cell-like properties:
![Page 58: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/58.jpg)
In summary: Cancers can arise from stem cells
orCancers can arise from differentiated cells
“Cancer stem cells” can refer to the stem cells from which some cancers start,BUT generally refer to the:cells within a tumor that have stem cell like properties:
i.e. slow cyclingself-renewalmultidrug resistancehypoxia resistantradio-insensitive
![Page 59: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/59.jpg)
In summary: Cancers can arise from stem cells
orCancers can arise from differentiated cells
“Cancer stem cells” can refer to the stem cells from which some cancers start,BUT generally refer to the: cells within a tumor that have stem cell like properties:
i.e. slow cyclingself-renewalmultidrug resistancehypoxia resistantradio-insensitive
and therefore are resistant to therapy and responsible fortumor recurrence…
![Page 60: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/60.jpg)
cells within a tumor that have stem cell like properties:i.e. slow cycling
self-renewalmultidrug resistancehypoxia resistantradio-insensitive
and therefore are resistant to therapy and responsible fortumor recurrence…
Antigenic Markers: CD133c-kitEpCAMKeratin 19
Functional Markers: Side populationLabel retaining cells
![Page 61: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/61.jpg)
Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications.
Marquardt JU, Factor VM, Thorgeirsson SS.
J Hepatol. 2010; 53: 568.
Stem cell plasticity: recapping the decade, mapping the future.
Theise ND.
Exp Hematol. 2010; 38: 529.
FURTHER READING
![Page 62: APASL 1000 1030 n.theise](https://reader033.fdocuments.us/reader033/viewer/2022061213/54972354ac7959132e8b5302/html5/thumbnails/62.jpg)